Which insiders are trading Valeant Pharmaceuticals International, Inc. (VRX)?

Davide Leone & Partners Investment Company Llp decreased Shire Plc (SHPG) stake by 28.53% reported in 2016Q4 SEC filing. The stock rose 1.41% or $2.04 reaching $146.64. Similar statistics are true for the second largest owner, Valueact Holdings, L.P., which owns 17,997,224 shares of the stock are valued at $254.48 million. (NASDAQ:AMGN) has risen 5.27% since August 28, 2016 and is uptrending. It has outperformed by 43.18% the S&P500.

Gam Holding Ag decreased Entergy Corp New (ETR) stake by 48.37% reported in 2016Q4 SEC filing. Stoneridge Prtn Ltd Liability Corp stated it has 0.19% of its portfolio in Valeant Pharmaceuticals Intl Inc (NYSE:VRX). (VRX) belonging to the Healthcare sector has declined -4.14% and closed its last trading session at $14.14. About 5.79M shares traded. Overland Advisors Llc acquired 1.00M shares as Valeant Pharmaceuticals Intl (Put) (VRX)’s stock declined 15.71%. It has underperformed by 65.21% the S&P500.

Since March 13, 2017, it had 3 buys, and 1 sale for $166.26 million activity. The stock of Valeant Pharmaceuticals Intl Inc (NYSE:VRX) has “Hold” rating given on Monday, November 14 by Deutsche Bank.

In the transaction dated March 14, 2017, the great number of shares acquired came courtesy the EVP and CFO; Herendeen Paul added a total of 24,000 shares at an average price of $10.72, amounting to approximately $257,280. BMO Capital Markets downgraded Valeant Pharmaceuticals Intl Inc (NYSE:VRX) on Thursday, October 22 to “Market Perform” rating. (VRX) in trading session dated August 21, 2017.

Investors sentiment decreased to 1.08 in 2016 Q4. Its up 0.15, from 0.76 in 2016Q3. 49 funds opened positions while 82 raised stakes. 11, 2017. The company’s shares were assimilated at $13.9 per share worth to an investment of some $278,000 on account of De Schutter Richard U. The company beat the analyst EPS Estimate with the difference of $0.09. Diamond Hill Cap Mngmt Inc owns 34,500 shares for 0% of their portfolio. First Manhattan Com invested 0% in Valeant Pharmaceuticals Intl Inc (NYSE:VRX). The company has Beta Value of -0.34 and ATR value of 0.62. 561.98 million shares or 1.23% less from 568.98 million shares in 2016Q3 were reported. Riverpark Advsr Ltd Com has invested 0.11% in Valeant Pharmaceuticals Intl Inc (NYSE:VRX). 1832 Asset Management Lp, a Ontario – Canada-based fund reported 801,042 shares. Amp Cap Ltd holds 0.01% in Valeant Pharmaceuticals Intl Inc (NYSE:VRX) or 141,214 shares. Douglass Winthrop Ltd Liability Co has invested 2.13% in Amgen, Inc. For the past 5 years, the company’s revenue has grown -14.7%, while the company’s earnings per share has grown -51.2%. George Kaiser Family Foundation holds 29,382 shares. Laurion Cap Management Lp has invested 0.14% in Valeant Pharmaceuticals Intl Inc (NYSE:VRX). Toronto Dominion Bancshares holds 0.32% or 7.55M shares. 110,574 were reported by Zurcher Kantonalbank (Zurich Cantonalbank).

Among 21 analysts covering United Continental (NYSE:UAL), 11 have Buy rating, 0 Sell and 10 Hold. Entergy Corporation had 42 analyst reports since July 28, 2015 according to SRatingsIntel. The rating was maintained by Stifel Nicolaus on Thursday, May 11 with “Buy”. Morgan Stanley maintained the stock with “Overweight” rating in Thursday, April 28 report. The firm has “Hold” rating by TD Securities given on Wednesday, July 20. The firm earned “Hold” rating on Tuesday, July 25 by Piper Jaffray. The firm has “Buy” rating by Oppenheimer given on Wednesday, August 16. Rodman & Renshaw has “Buy” rating and $150 target. RBC Capital Markets maintained the stock with “Sector Perform” rating in Wednesday, October 12 report. The stock has “Underperform” rating by Bank of America on Tuesday, November 22. The rating was maintained by RBC Capital Markets with “Outperform” on Tuesday, January 26. Therefore 82% are positive. Expedia Inc. had 77 analyst reports since July 24, 2015 according to SRatingsIntel. The firm has “Underweight” rating given on Friday, April 29 by JP Morgan. As per Wednesday, August 23, the company rating was initiated by Berenberg. The rating was downgraded by TheStreet on Saturday, August 15 to “Buy”. The firm has “Hold” rating given on Friday, August 11 by Canaccord Genuity. Whereas 5 of them predict the stock is a hold. The company was maintained on Wednesday, October 14 by Mizuho. The firm has “Hold” rating given on Friday, June 10 by Jefferies. Canaccord Genuity maintained it with “Hold” rating and $6800 target in Thursday, July 6 report. The idea is that more recent information is, generally speaking, more accurate and can be a better predictor of the future, which can give investors an advantage in earnings season.

In the past 5 years, the stock showed growth of 61.43% per annum.

The next earnings announcement is expected on Nov 06, 2017.

Investors sentiment increased to 1.24 in 2016 Q4.

Since February 28, 2017, it had 0 buys, and 2 insider sales for $1.02 million activity. It dropped, as 24 investors sold AZPN shares while 98 reduced holdings. 80 funds opened positions while 126 raised stakes. After this purchase, 25,190 common shares of VRX are directly owned by the insider, with total stake valued at $356,187. Mitsubishi Ufj Tru Bk has invested 0.03% in United Continental Holdings Inc (NYSE:UAL). (NASDAQ:AMGN) or 3,700 shares. The Connecticut-based Benin Mgmt Corporation has invested 0.24% in Amgen, Inc. Davenport And Co owns 244,970 shares for 0.51% of their portfolio. The stock declined 0.10% or $0.07 reaching $72.75 per share. Jaffetilchin Prns Limited Liability Com holds 6,096 shares. (NASDAQ:AZPN) for 152,634 shares. Tower Rech Capital Lc (Trc) accumulated 0% or 1,134 shares. (NASDAQ:AZPN). State Board Of Administration Of Florida Retirement holds 0.01% or 60,177 shares. 6,949 are held by Parametrica Mgmt Ltd. Jennison Assocs Ltd Liability holds 12,798 shares. Dupont Capital Mgmt Corp invested in 0.23% or 191,710 shares.

Receive News & Ratings Via Email – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings with MarketBeat.com’s FREE daily email newsletter.

Leave a Reply

Your email address will not be published. Required fields are marked *